Literature DB >> 17666502

Treatment of depression in primary care. Socio-economic status, clinical need and receipt of treatment.

Scott Weich1, Irwin Nazareth, Louise Morgan, Michael King.   

Abstract

BACKGROUND: Depression is prevalent, costly and often undertreated. AIMS: To test the hypothesis that people with low socio-economic status are least likely to receive and adhere to evidence-based treatments for depression, after controlling for clinical need.
METHOD: Individuals with an ICD-10 depressive episode in the past 12 months (n=866) were recruited from 7271 attendees in 36 general practices in England and Wales. Depressive episodes were identified using the 12-month Composite International Diagnostic Interview. Treatment receipt and adherence were assessed by structured interview, and rated using evidence-based criteria.
RESULTS: We identified 332 individuals (38.3%) who received and adhered to evidence-based treatment. There were few socio-economic differences in treatment allocation. Although those without educational qualifications were least likely to receive psychological treatments (OR = 0.55,95% CI 0.34-0.89, P = 0.02), this association was not statistically significant after adjusting for depression severity.
CONCLUSIONS: We found no evidence of inverse care in the treatment of moderate and severe depression in primary care in England and Wales.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17666502     DOI: 10.1192/bjp.bp.106.032219

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  13 in total

1.  Investigating the use of NICE guidelines and IAPT services in the treatment of depression.

Authors:  Alex Gyani; Neil Pumphrey; Hannah Parker; Roz Shafran; Suzanna Rose
Journal:  Ment Health Fam Med       Date:  2012-09

Review 2.  Drug-gut microbiota interactions: implications for neuropharmacology.

Authors:  Jacinta Walsh; Brendan T Griffin; Gerard Clarke; Niall P Hyland
Journal:  Br J Pharmacol       Date:  2018-06-28       Impact factor: 8.739

3.  Antidepressants utilization among elderly in Lombardy from 2000 to 2007: dispensing trends and appropriateness.

Authors:  Alberto Parabiaghi; Carlotta Franchi; Mauro Tettamanti; Angelo Barbato; Barbara D'Avanzo; Ida Fortino; Angela Bortolotti; Luca Merlino; Alessandro Nobili
Journal:  Eur J Clin Pharmacol       Date:  2011-05-07       Impact factor: 2.953

4.  Factors associated with duration of new antidepressant treatment: analysis of a large primary care database.

Authors:  Christopher Burton; Niall Anderson; Katie Wilde; Colin R Simpson
Journal:  Br J Gen Pract       Date:  2012-02       Impact factor: 5.386

5.  Influences of income and employment on psychological distress and depression treatment in Japanese adults.

Authors:  Yoshiharu Fukuda; Ayako Hiyoshi
Journal:  Environ Health Prev Med       Date:  2011-03-16       Impact factor: 3.674

6.  Variations of depression treatment among women with hypertension.

Authors:  Elvonna V Atkins; Usha Sambamoorthi; Rituparna Bhattacharya
Journal:  Health Care Women Int       Date:  2015-01-22

7.  Inequalities in therapeutic treatment during cardiac inpatient rehabilitation in Germany.

Authors:  Thomas Altenhöner; Carolin Baczkiewicz; Heide Weishaar; Marcus Kutschmann
Journal:  Int J Public Health       Date:  2011-09-06       Impact factor: 3.380

8.  The drugs don't work? antidepressants and the current and future pharmacological management of depression.

Authors:  Elizabeth Penn; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2012-10

9.  Recorded quality of care for depression in general practice: an observational study.

Authors:  Sivatharan Vedavanam; Nicholas Steel; Joanne Broadbent; Susan Maisey; Amanda Howe
Journal:  Br J Gen Pract       Date:  2009-02       Impact factor: 5.386

10.  Modelling the cost-effectiveness of preventing major depression in general practice patients.

Authors:  R M Hunter; I Nazareth; S Morris; M King
Journal:  Psychol Med       Date:  2013-08-15       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.